Recombinant oadG2 is the gamma chain of the OAD enzyme, encoded by the oadG2 gene (also known as STM3353). Key identifiers include:
Parameter | Details |
---|---|
Gene Name | oadG2 (Synonyms: oadG, STM3353) |
UniProt ID | Q03032 |
NCBI GenBank | NC_003197.1 |
Protein Length | Full-length (84 amino acids) |
Source Organism | Salmonella typhimurium (strain LT2 / SGSC1412 / ATCC 700720) |
The protein’s amino acid sequence begins with MTNAALLLGEGFTLMFLGMGFVLAFLFLLIFAIRGMSAAVNRFFPEPAPAPKAAPAAAAPVVDDFTRLKPVIAAAIHHHHRLNA (His-tag appended for purification) .
oadG2 participates in the OAD enzyme’s sodium-dependent activity:
Process | Mechanism | Relevance |
---|---|---|
Carboxyl-Biotin Decarboxylation | Converts oxaloacetate to pyruvate, releasing CO₂. | Central to metabolic pathways (e.g., gluconeogenesis). |
Sodium Transport | Coupled Na⁺ extrusion via an “elevator mechanism” in the β subunit. | Maintains cellular ion homeostasis. |
This coupling ensures efficient energy conversion, with oadG2 stabilizing the β subunit’s conformation during Na⁺ translocation .
Recombinant oadG2 is typically expressed in heterologous systems:
oadG2 is utilized in:
Structural Coupling: The β3γ3 hetero-hexamer’s γ subunits (oadG2) interact via hydrophobic residues to stabilize the β subunit’s Na⁺-binding pocket .
Elevator Mechanism: Sodium transport involves conformational shifts in the β subunit, driven by decarboxylation energy .
Functional Residues: Mutagenesis studies identified critical residues (e.g., D44, R140) in the β subunit for Na⁺ binding and transport .
KEGG: stm:STM3353
STRING: 99287.STM3353
The oadG2 protein differs from other OAD components in several key aspects:
Feature | oadG2 (γ subunit) | OadA (α subunit) | OadB (β subunit) |
---|---|---|---|
Size | 9-10 kDa (84 aa) | 63-65 kDa (~520 aa) | 40-45 kDa |
Location | Membrane-associated | Soluble with multiple domains | Membrane-embedded |
Tryptophan residues | None | 5 residues | 1 residue |
Primary function | Structural stability | Carboxyltransferase activity | Na+ transport |
Domains | Single domain structure | Three domains (N-terminal catalytic, biotin-binding, association) | Transmembrane domains |
The α subunit contains the carboxyltransferase catalytic site in its N-terminal domain and a biotin-binding domain at its C-terminus, connected by a 40-amino acid flexible linker rich in proline and alanine . The β subunit is involved in sodium ion transport. In contrast, oadG2 lacks catalytic activity but plays a crucial structural role in complex assembly and stability through its interaction with the α subunit .
The production of high-quality recombinant oadG2 requires specific expression and purification protocols:
Expression System:
E. coli is the preferred heterologous expression system for recombinant Salmonella typhimurium oadG2
The full-length protein (amino acids 1-84) should be expressed with an N-terminal His-tag for purification purposes
Purification Protocol:
Transform expression vector containing oadG2 gene into competent E. coli cells
Culture cells in LB medium with appropriate antibiotics at 37°C until OD600 reaches 0.6-0.8
Induce protein expression with IPTG (typically 0.5-1 mM)
Harvest cells by centrifugation after 4-6 hours of induction
Lyse cells using sonication or mechanical disruption in appropriate buffer
Purify using Ni-NTA affinity chromatography, leveraging the His-tag
Elute with imidazole gradient (20-250 mM)
Dialyze against storage buffer
Storage Considerations:
Store lyophilized protein at -20°C to -80°C
After reconstitution, store at 4°C for up to one week
For long-term storage of reconstituted protein, add glycerol to 5-50% final concentration (recommended 50%) and store at -20°C/-80°C
Avoid repeated freeze-thaw cycles as they may compromise protein integrity
Verification of recombinant oadG2 expression and functionality requires multiple analytical approaches:
Expression Verification:
SDS-PAGE analysis: Should show a band at approximately 10 kDa corresponding to the His-tagged oadG2 protein
Western blot using anti-His antibodies to confirm identity of the expressed protein
Purity assessment: Protein should be >90% pure as determined by SDS-PAGE
Functional Verification:
Complex assembly assay: Test ability of purified oadG2 to form complexes with α and β subunits using size exclusion chromatography
Structural integrity analysis: Secondary structure analysis using circular dichroism spectroscopy
Binding assay: Measure interaction with the α subunit using surface plasmon resonance or pull-down assays
Fluorescence spectroscopy: Although oadG2 lacks tryptophan residues, monitoring changes in the fluorescence of the α subunit in the presence of oadG2 can indicate proper complex formation
Advanced Verification:
Mass spectrometry to confirm the exact molecular weight and sequence integrity
Functional reconstitution of the complete OAD complex and measurement of enzymatic activity
Structural studies using X-ray crystallography or cryo-electron microscopy to verify proper folding
The role of oadG2 in Salmonella pathogenesis is complex and can be studied through various experimental approaches:
Pathogenic Significance:
OAD enzymes contribute to bacterial metabolism under anaerobic conditions, potentially providing a survival advantage in oxygen-limited environments like the intestinal lumen
The enzyme complex may contribute to Salmonella's ability to adapt to different host environments by facilitating alternative metabolic pathways
The link between oxaloacetate metabolism and virulence has been implicated in bacterial persistence during infection
Experimental Models:
In vitro infection models:
Cell culture systems using intestinal epithelial cells or macrophages
Growth assays comparing wild-type and oadG2-knockout strains under anaerobic conditions
Animal infection models:
Detection methods:
Research has shown that following oral infection, S. Typhimurium can colonize reproductive organs of laying hens and contaminate egg shells, though at varying frequencies depending on experimental conditions . The detection sensitivity for S. Typhimurium in fecal samples has been reported as 10² CFU/reaction by PCR, but this decreases to 10⁴ CFU/reaction in mixed infections .
Substrate and inhibitor binding to the OAD complex induces significant structural changes that can be monitored through various biophysical techniques:
Structural Dynamics:
Binding of oxomalonate (a competitive inhibitor) to the carboxyltransferase site on the α subunit causes detectable structural changes measurable by fluorescence spectroscopy
These changes primarily affect the α subunit, which contains 5 tryptophan residues, some located near the catalytic site
The β subunit, with its single tryptophan residue, shows lesser spectroscopic shifts upon oxomalonate binding
oadG2 Influence on Structural Changes:
The αγ complex (α subunit plus oadG2) exhibits a significant red edge excitation shift (REES) of +44.4 nm (emission shifts from 334 nm to 378.4 nm when excitation shifts from 275 nm to 307 nm)
Addition of oxomalonate to the αγ complex induces a further +12.4 nm shift in REES
These findings suggest that oadG2 itself does not significantly alter the substrate/inhibitor binding properties of the α subunit but rather serves as a structural stabilizer
Experimental Approaches to Study These Changes:
Fluorescence spectroscopy: Particularly useful for monitoring conformational changes upon substrate binding
Hydrogen-deuterium exchange mass spectrometry: Can reveal regions of altered solvent accessibility
Cryo-electron microscopy: May reveal larger-scale conformational changes in the complex
Molecular dynamics simulations: Can predict and visualize structural alterations at atomic resolution
PCR-based detection of Salmonella Typhimurium faces several challenges that researchers should address:
Common Challenges:
Limited sensitivity in mixed infections: Detection limit for S. Typhimurium decreases from 10² CFU/reaction to 10⁴ CFU/reaction when samples contain multiple Salmonella serovars
PCR inhibitors in biological samples: Fecal samples contain various inhibitors that can reduce PCR efficiency
DNA interference from other microflora: Abundant microflora DNA can compete with target sequences
Gradual reduction of Salmonella in samples: Bacterial counts may decrease over time, further challenging detection
Optimization Strategies:
Sample preparation improvements:
Use specialized DNA extraction methods designed for fecal or environmental samples
Include inhibitor removal steps such as additional purification columns
Apply selective enrichment before PCR to increase target organism concentration
PCR protocol optimization:
Alternative detection approaches:
Combine culture methods with PCR for increased sensitivity
Use qPCR instead of conventional PCR for quantitative assessment
Consider digital PCR for absolute quantification even in complex samples
Research has shown that standard culture methods can be more sensitive than PCR assays in detecting S. Typhimurium in some biological samples, suggesting a complementary approach may yield optimal results .
Maintaining functional integrity of recombinant oadG2 requires careful attention to reconstitution and storage conditions:
Reconstitution Protocol:
Centrifuge the vial briefly before opening to bring contents to the bottom
Reconstitute the lyophilized protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL
Allow complete dissolution by gentle mixing, avoiding vigorous vortexing
For long-term storage, add glycerol to a final concentration of 5-50% (recommended: 50%)
Storage Conditions:
Short-term storage (up to one week): Store working aliquots at 4°C
Long-term storage: Store at -20°C/-80°C after aliquoting to minimize freeze-thaw cycles
Buffer considerations: Tris/PBS-based buffer with 6% Trehalose, pH 8.0 has been demonstrated to maintain stability
Functional Integrity Assessment:
Periodically test protein integrity by SDS-PAGE
Verify complex-forming ability with the α subunit
Monitor secondary structure using circular dichroism after extended storage periods
Common Stability Issues and Solutions:
Issue | Possible Cause | Solution |
---|---|---|
Aggregation | Improper reconstitution | Reconstitute more slowly, at lower concentration |
Activity loss | Repeated freeze-thaw | Prepare smaller aliquots for single use |
Precipitation | Buffer incompatibility | Optimize buffer composition or pH |
Degradation | Protease contamination | Add protease inhibitors |
Recent structural studies have provided valuable insights into OAD complex architecture:
Current Structural Knowledge:
Structural information on OAD is currently limited primarily to the carboxyltransferase domain of the α subunit, which forms a dimer
The γ subunit (oadG2) plays a critical role in complex assembly but has less structural data available
Spectroscopic studies using fluorescence have revealed insights into conformational changes upon substrate analog binding
Emerging Approaches:
Cryo-electron microscopy (cryo-EM):
Allows visualization of large membrane protein complexes without crystallization
Can potentially reveal the complete OAD complex architecture including oadG2's position
May capture different conformational states during the catalytic cycle
Integrative structural biology:
Combining multiple techniques (X-ray crystallography, NMR, cross-linking mass spectrometry)
Can provide complementary structural information at different resolutions
Computational approaches:
Molecular dynamics simulations to study dynamic interactions
Homology modeling based on related membrane protein complexes
Research Implications:
Complete structural understanding will elucidate how the small oadG2 protein contributes to complex stability
May reveal potential interface regions for targeted disruption as antimicrobial strategies
Could identify conformational changes during catalysis that depend on proper complex assembly
The unique characteristics of oadG2 offer several promising applications in both diagnostics and therapeutics:
Diagnostic Applications:
Targeted PCR diagnostics:
Serological detection:
Development of antibodies against oadG2 for immunoassays
Potential for lateral flow or ELISA-based rapid diagnostics
Biosensor development:
Immobilized oadG2 or anti-oadG2 antibodies on biosensor surfaces
Integration with microfluidic platforms for automated detection
Potential for field-applicable diagnostic tools
Therapeutic Applications:
Antimicrobial target:
Disruption of the oadG2-α subunit interaction could destabilize the OAD complex
Small molecule inhibitors targeting this interaction might reduce bacterial survival
Peptide-based approaches mimicking interface regions could compete for binding
Vaccine development:
Recombinant oadG2 as a potential component in subunit vaccines
DNA vaccines encoding oadG2 alongside other Salmonella antigens
Attenuated vaccine strains with modified oadG2 expression
Drug delivery:
Engineered bacteria expressing modified oadG2 for targeted delivery of therapeutic molecules
Nanoparticle conjugation with oadG2 for targeted drug delivery to infected tissues
Current research is still primarily focused on understanding fundamental aspects of oadG2 function and structure, but these findings are laying the groundwork for future translational applications in both diagnostics and therapeutics for Salmonella infections.